NCT04008433View on ClinicalTrials.gov

Median Effective Dose of Lidocaine for the Prevention of Pain Caused by the Injection of Propofol Formulated With Medium-/Long-chain Triglycerides

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 16, 2018

Primary Completion Date

November 16, 2018

Study Completion Date

June 13, 2019

Conditions
LidocaineInjection Pain
Interventions
DRUG

Lidocaine

Advanced intravenous injection of lidocaine before the propofol injection

Trial Locations (1)

225012

the Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou

All Listed Sponsors
lead

Yangzhou University

OTHER

NCT04008433 - Median Effective Dose of Lidocaine for the Prevention of Pain Caused by the Injection of Propofol Formulated With Medium-/Long-chain Triglycerides | Biotech Hunter | Biotech Hunter